by SpringTide | Dec 1, 2022
SpringTide was a major investor in PathologyWatch’s $3M Seed round in early 2019, and took a board seat at that time. We continued to support the company through 2019, building the in-house sales force, and led PathologyWatch’s $5M Series A round in early 2020,...
by SpringTide | Dec 1, 2022
Under the Microscope: PathologyWatch Cofounder April Larson Comes by Love of Health Care Naturally The business world is full of entrepreneurs from all fields putting a lot of blood, sweat, and tears into the success of their enterprises. Few of them, however, can...
by SpringTide | Dec 1, 2022
Clinicians don’t need to take a blood, sweat, and tears sample to arrive at the diagnosis that clinician burnout is at an all-time high and health systems are struggling to provide the support and tools needed amid large financial losses. For healthcare innovators...
by SpringTide | Dec 1, 2022
Guillaume Cohen-Skalli first became intrigued about finding a solution to the world’s under-the-radar hypothyroidism problem after watching a close friend struggle through multiple misdiagnoses of the disease—a struggle that lasted years. His friend met with five...
